Literature DB >> 3924551

Haemodynamic effects of class I antiarrhythmic agents.

V Legrand, P Collignon.   

Abstract

In order to choose the most appropriate antiarrhythmic agent, the basic haemodynamic characteristics of class I antiarrhythmic agents must be known. Class Ia agents, quinidine and procainamide, have minor haemodynamic effects, while disopyramide causes serious left ventricular depression. Class Ib drugs are exceptionally well tolerated, and class Ic agents have the potential for adverse haemodynamic effects in patients with left ventricular dysfunction. In this article, haemodynamic effects of class I antiarrhythmic agents are described, with particular emphasis on their clinical implications.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924551     DOI: 10.2165/00003495-198500294-00011

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  23 in total

1.  Value and hazards of intravenous procaine amide ("pronestyl") therapy.

Authors:  N S STEARNS; E J CALLAHAN; L B ELLIS
Journal:  J Am Med Assoc       Date:  1952-02-02

2.  Cardiogenic shock and disopyramide phosphate.

Authors:  J R Story; A M Abdulla; M J Frank
Journal:  JAMA       Date:  1979-08-17       Impact factor: 56.272

3.  Effect of loading dose of procaine amide on left ventricular performance in man.

Authors:  G Jawad-Kanber; T R Sherrod
Journal:  Chest       Date:  1974-09       Impact factor: 9.410

Review 4.  Hemodynamic effects of antiarrhythmic drugs.

Authors:  P J Block; R A Winkle
Journal:  Am J Cardiol       Date:  1983-09-22       Impact factor: 2.778

5.  Congestive heart failure caused by oral disopyramide.

Authors:  P J Podrid; A Schoeneberger; B Lown
Journal:  N Engl J Med       Date:  1980-03-13       Impact factor: 91.245

6.  Myocardial depression with disopyramide.

Authors:  D J Bauman
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

7.  Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine.

Authors:  V Kötter; T Linderer; R Schröder
Journal:  Am J Cardiol       Date:  1980-09       Impact factor: 2.778

8.  Hemodynamic effects of intravenously administered quinidine on the transplanted human heart.

Authors:  J W Mason; R A Winkle; N B Ingels; G T Daughters; D C Harrison; E B Stinson
Journal:  Am J Cardiol       Date:  1977-07       Impact factor: 2.778

9.  Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.

Authors:  V Legrand; M Vandormael; P Collignon; H E Kulbertus
Journal:  Am J Cardiol       Date:  1983-02       Impact factor: 2.778

Review 10.  Antiarrhythmic treatment: an overview.

Authors:  J T Bigger
Journal:  Am J Cardiol       Date:  1984-02-27       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.